Universal Price To Sales Ratio from 2010 to 2024
| UHT Stock | USD 40.65 0.48 1.19% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 6.23849856 | Current Value 7.93 | Quarterly Volatility 3.90852771 |
Check Universal Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Universal Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 M, Interest Expense of 23.1 M or Total Revenue of 100.4 M, as well as many indicators such as Price To Sales Ratio of 7.93, Dividend Yield of 0.0793 or PTB Ratio of 2.06. Universal financial statements analysis is a perfect complement when working with Universal Health Valuation or Volatility modules.
Universal | Price To Sales Ratio |
Latest Universal Health's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Universal Health Realty over the last few years. Price to Sales Ratio is figured by comparing Universal Health Realty stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Universal Health sales, a figure that is much harder to manipulate than other Universal Health Realty multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Universal Health's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Universal Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 5.64 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Universal Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 11.15 | |
| Geometric Mean | 10.58 | |
| Coefficient Of Variation | 35.04 | |
| Mean Deviation | 2.82 | |
| Median | 10.40 | |
| Standard Deviation | 3.91 | |
| Sample Variance | 15.28 | |
| Range | 14.647 | |
| R-Value | (0.23) | |
| Mean Square Error | 15.61 | |
| R-Squared | 0.05 | |
| Significance | 0.42 | |
| Slope | (0.20) | |
| Total Sum of Squares | 213.87 |
Universal Price To Sales Ratio History
About Universal Health Financial Statements
Universal Health shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Universal Health investors may analyze each financial statement separately, they are all interrelated. The changes in Universal Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on Universal Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 6.24 | 7.93 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Universal Stock Analysis
When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.